Address	2401 4th Avenue Seattle Washington 98121 United States
Employees	-
Website	http://aptevotherapeutics.com
Updated	07/08/2019
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline includes Otlertuzumab, APVO414, APVO436, ROR1 Candidate, and ALG. APV-527.